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Summary:  
Children with cystic fibrosis undergoing lung transplant harbour multiple subpopulations of M. 
abscessus. Subpopulations can have different antimicrobial resistance genotypes. Sputum 
isolates do not reflect the genetic diversity within a patient.   
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Abstract  
Background: Children with cystic fibrosis (CF) can develop life-threatening infections of 
Mycobacterium abscessus. These present a significant clinical challenge, particularly when the 
strains involved are resistant to antibiotics. Recent evidence of within-patient subclones of M. 
abscessus in adults with CF suggests the possibility that within-patient diversity may be relevant 
for the treatment of pediatric CF patients.  
Methods: We performed whole genome sequencing (WGS) on 32 isolates of M. abscessus from 
multiple body sites for two patients with CF undergoing treatment at Great Ormond Street 
Hospital, UK, in 2015. 
Results: We found evidence of extensive diversity within patients over time. Clustering analysis 
of single nucleotide variants (SNVs) revealed that each patient harboured multiple 
subpopulations, which were differentially abundant between sputum, lung samples, chest 
wounds, and pleural fluid. Sputum isolates did not reflect overall within-patient diversity, 
including failing to detect subclones with mutations previously associated with macrolide 
resistance (rrl 2058/2059). Some variants were present at intermediate frequencies before 
lung transplant. The time of transplant coincided with extensive variation, suggesting that this 
event is particularly disruptive for the microbial community, but transplant did not clear the M. 
abscessus infection and both patients died as a result of this infection. 
Conclusions: Isolates of M. abscessus from sputum do not always reflect the entire diversity 
present within the patient, which can include subclones with differing antimicrobial resistance 
profiles. Awareness of this phenotypic variability, with sampling of multiple body sites in 
conjunction with WGS, may be necessary to ensure the best treatment for this vulnerable 
patient group. 
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Introduction 
Mycobacterium abscessus is a nontuberculous mycobacteria (NTM) which has recently emerged 
as a major pathogen in cystic fibrosis (CF) patients1. Infection with M. abscessus is associated 
with poor clinical outcomes, particularly in conjunction with lung transplantation2. Treatment is 
challenging due to the intrinsic resistance of M. abscessus to many classes of antibiotics3, along 
with certain genotypes drastically altering the efficacy of antibiotics4. The antimicrobial 
resistance (AMR) profile of isolates is highly relevant for treatment, but current diagnostic work 
mainly uses isolates from sputum, which may not reflect the full range of genetic diversity 
within the patient and therefore fail to recover the true AMR profile. 
Minority variants from WGS have been used to infer the presence of multiple subpopulations 
(subclones) in longitudinal sputum isolates of M. abscessus5. However, it remains an open 
question whether patients harbour further unsampled genetic diversity. The lung is known to 
be capable of harbouring considerable pathogen diversity in chronic infections. For example, M. 
tuberculosis infections exist as multiple subpopulations with different AMR profiles6,7. The 
potential relevance of this genetic diversity for treatment is not yet known. 
For this reason, we investigated longitudinal isolates from two patients infected with M. 
abscessus subsp. abscessus undergoing lung transplant at Great Ormond Street Hospital (Figure 
1), and identified variable genomic positions within samples (single nucleotide variants, SNVs). 
By including isolates from sputum samples but also biologically important compartments such 
as pleural fluid, lung tissue, and swabs from chest wounds, we aimed to establish the extent and 
significance of within-patient variation in M. abscessus for this vulnerable group. 
  
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciz069/5301759 by guest on 05 February 2019
 M. abscessus subclones in CF patients 
5 
 
 
 
 
Methods 
Patient cohort and sample collection 
Great Ormond Street Hospital (GOSH) is a large regional centre for paediatric CF patients and 
the largest paediatric lung transplant centre in the UK. The two patients in this study (Patient 1 
and Patient 2) were from other CF centres and were seen at GOSH for a transplant assessment, 
during the lung transplant procedure, and post-transplant (Table 1). Both patients in this study 
underwent regular respiratory microbiological diagnostic investigations, including specific stain 
and culture for mycobacteria on sputum pre- and post-transplant, and explanted lung tissue, 
bronchoalveolar lavage, pleural fluid and clamshell incision wound swabs post-transplant. All 
further microbiological investigations were carried out on ‘sweeps’ from pure culture plates. All 
M. abscessus isolates cultured in our laboratory are identified to sub-species level by PCR and 
sequencing of hsp65 and rpoB genes and inducible macrolide resistance predicted by PCR and 
sequencing of the erm(41) gene as previously described8. VNTR profiles were obtained for 
selected isolates as previously described9. Phenotypic sensitivity data was obtained from the 
mycobacterial reference laboratory (Table 3).  
Demographic and clinical data were extracted from the Patient Administration System (PIMS) 
and microbiological data from the Laboratory Information Management system (OMNI-client 
ISS) using SQL databases and Excel spreadsheets. Additional sources of information included CF 
and transplantation databases. Details of antimicrobial therapy administered prior to 
transplantation was provided by the referring CF centres. All investigations were performed in 
accordance with the Hospitals Research governance policies and procedures.  
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Whole genome sequencing  
16 isolates from Patient 1 and 16 isolates from Patient 2 (Figure 1, Table 2) underwent DNA 
extraction as previously described9 with the addition of a bead beating step. Total DNA 
concentration was determined using the Qubit high-sensitivity (HS) assay kit (Thermofisher) 
and a sequencing library was prepared from 50 ng of DNA using the Nextera Library 
Preparation kit (Illumina). Post-PCR clean-up was carried out using Ampure XP beads 
(Beckman). Library size was validated using the Agilent 2200 TapeStation with Agilent D1000 
ScreenTape System and 150bp paired-end reads were sequenced on Illumina NextSeq 550 
system. Raw sequencing reads have been deposited on ENA (Study Accession PRJEB28875) as 
well as two assemblies used as ‘de novo references’ (see below).  
Sequence data analysis 
Initial variable nucleotide tandem repeat (VNTR) typing carried out as described previously9,10 
suggested the possibility of mixed infections, based on results intermediate between VNTR I and 
the closely related VNTR I* profile (differing at one locus). A preliminary mapping of all isolates 
to the standard M. abscessus strain ATCC 19977 chromosome (NCBI Accession: CU458896.1) 
showed that the mean coverage at 10X was ~91%, contrasted with >99% for a representative 
set of VNTR II isolates from another patient sequenced with the same protocol (not shown). In 
order to ensure we captured as much genetic diversity as possible, we therefore adopted a 
hybrid de novo and mapping approach. We selected the first isolate (temporally) for each 
patient and performed de novo assembly with Spades v3.10.0 with the --careful switch and 
otherwise default parameters11. After removing contigs with <10,000 bases to exclude small 
mobile genetic elements, this first de novo assembly was used as a new reference to map raw 
reads from other isolates using bwa mem v0.7.12 with default parameters12. This produced ‘de 
novo references’ for Patient 1 and Patient 2 containing 5.17Mb and 5.28Mb respectively (Table 
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1). Contigs were reordered against the M. abscessus ATCC 19977 chromosome using Mauve 
v2.4.0 (2015-02-25)13. 
Variant identification and clustering analysis 
In brief, the mapping file was sorted and indexed using picard v1.130, then GATK v3.30 was 
used to create a combined variant call format (VCF) file for each patient. Each position required 
a mapping depth > 30 in all samples from a patient to be included in downstream analysis. We 
manually inspected the ‘self-mapping’ of the reads from the first temporal sample to its own de 
novo assembly using IGV v2.4.1014 to identify small regions where mapping was problematic. 
We removed SNVs within isolated regions where the self-mapping had unexpected peaks in 
coverage (Patient 1: contigs 12 (12,575-13,519bp) and 19 (96,916-97,032bp); Patient 2: contig 
17 (12,718-12,770bp) as well as SNVs where the reference allele fraction from the self-mapping 
reads was < 5%. 
As noted by Bryant et al.5, patterns of linkage of variants in for M. abscessus can be suggestive of 
the existence of subpopulations. We aimed to establish a conservative lower bound for the 
number of clonal subpopulations within a patient, inferring their existence from the linkage 
patterns of variant frequencies across all samples. Patterns of linkage disequilibrium can also 
occur due to recombination, so we therefore attempted to remove local recombination in our 
analysis. Using the SNVs obtained via the mapping and filtering methods described above, we 
hierarchically clustered SNVs using Ward’s minimum variance criterion15 applied to Euclidean 
distances between allele frequencies with a dissimilarity threshold of 1 to define clusters. We 
removed clusters containing <4 SNVs. We also removed putative local recombination regions by 
removing clusters where the SNVs were distributed within a total range < 100,000bp (~2% of 
the M. abscessus genome).  
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In general, the inference of haplotype frequencies using variant frequencies from short 
sequencing reads for a microbial population undergoing recombination is a complex problem16. 
However, as we are not attempting to comment on abundances of subpopulations but only their 
presence, we did not need to infer haplotype frequencies. Observing n distinct clusters of 
variants within a patient over time (i.e. allele frequencies that co-vary in step with each other) 
means that there must be at least n bacterial haplotypes within the population producing these 
patterns. This fact holds even when recombination is present. Therefore, observing distinct 
clusters of linked variants tells us that distinct subpopulations of M. abscessus exist within 
individual samples.  
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Results 
Individuals harbour extensive variation 
We observed multiple positions in the M. abscessus genome which varied between different 
isolates within a patient over time (total variable positions used for clustering across all 
isolates, Patient 1: 54 positions, Patient 2: 64 positions), although isolates remained highly 
similar on average and were clearly the same infecting strain (mean inter-isolate SNV distances 
Patient 1: 2.07 +/- 0.92 SNVs, Patient 2: 1.96 +/- 1.81 SNVs). Subsets of these SNVs showed 
patterns of linkage across the M. abscessus genome (Figure 2a). Similar clustered patterns of 
linked SNVs could also arise due to recombination, but clustered SNVs were widely spread 
across the genome suggesting the presence of multiple subclones. Even if recombination were 
present, leading to mixtures of clusters (i.e. different haplotypes), then the observed abundance 
patterns still require multiple subclones. A neighbour-joining tree produced from distances 
between isolates based on these allele frequencies also suggested multiple subclones (Figure 
2b).  
Within-patient variation includes antimicrobial resistance mutations 
Macrolide resistance in M. abscessus is driven by mutations at established positions in the rrl 
gene. Both patients received macrolides almost continuously throughout the six months prior to 
transplant (Figure 1). While initial isolates taken earlier in treatment were susceptible, we 
observed that resistance alleles at these positions (C/G) increased in abundance over time 
(Figure 3). Notably, all sputum isolates from Patient 1 showed a susceptible allele at position 
2059 whereas isolates from pleural fluid and clamshell incision wound swabs carried a 
resistance allele (A2059C, Figure 3a). There was also substantial variation within sets of isolates 
taken on the same day. For example, three isolates from different lymph node samples taken on 
the day of transplant for Patient 2 showed completely different macrolide resistance profiles, 
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most strikingly at position 2058 (Figure 3b). These positions were not among the SNVs 
clustered into subpopulation structure clusters in Patient 2, but rrl 2059 was part of cluster 1.D 
in Patient 1, demonstrating that these resistance alleles can arise spontaneously but also persist 
linked to genetic background. 
We also observed variable positions in the rrs gene in both patients (Figure 4). The rrs gene 
codes for 16S rRNA and is often a site of the emergence of aminoglycoside resistance (e.g. to 
amikacin), particularly the last few 100bp of the gene where the secondary structure of the 
rRNA can be affected by multiple mutations17. The de novo reference assembly for the gene in 
both patients was identical to the previously characterised sequence from amikacin-resistant M. 
abscessus17,18, which was consistent with the measured AMR phenotype of the first sputum 
sample in Patient 2 but not Patient 1 (Table 3). Subsequently, an isolate from lung tissue on the 
day of transplant had a different allele at position 1174 in patient 1 (C→T; Figure 4), and was 
partially resistant when phenotyped (Table 3), suggesting this mutation may have been 
involved in this resistance. In Patient 2, we observed both A and G at position 1374, 
corresponding to the A1400G mutation which confers high-level amikacin resistance in M. 
tuberculosis19. The G allele was dominant by the end of treatment, suggesting that it may have 
conferred higher resistance and/or been an important compensatory mutation. 
Other sites also showed high levels of variation in both patients. After sorting SNVs by the 
standard deviation of the reference allele fraction across isolates (Supplementary Dataset 1), 
the most highly variable position in Patient 1 was in the putative ferric uptake regulator FurB 
(MAB_1678c). This variant was present at high abundance in samples 49 days after transplant, 
with the reference allele fraction only present at <2% in one pleural fluid sample 
(Supplementary Dataset 1). Ferric uptake regulation has been associated with virulence of 
pathogenic mycobacteria; in mycobacterial infections the host response deprives the bacteria of 
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iron to prevent replication20. Iron is important for growth and virulence in M. abscessus21 with 
gallium used as a treatment because of its ability to inhibit iron-dependent enzymes22. The most 
variable position in Patient 2 was within a putative linoleoyl-CoA desaturase (MAB_2148), and 
the second most highly variable position in patient 2 was within the cell division control protein 
48 CDC48 (MAB_0347). Population heterogeneity via asymmetric cell division has been 
suggested as a factor facilitating the survival of M. tuberculosis across host physiological 
niches23, and the control of cell division is probably similarly important in the survival of M. 
abscessus across body sites. Both patients had a variable position within erm(41) (MAB_2297) 
although at different positions, which confers inducible resistance to macrolides24. 
Sputum samples do not reflect overall within-patient diversity 
The first sample from both patients was from sputum. Frequencies of the reference alleles were 
significantly associated with body site in Patient 2 (Kruskal-Wallis rank-sum test, p<0.001) but 
not Patient 1 (Kruskal-Wallis rank-sum test, p=0.13). Reference allele frequencies were 
significantly higher in subsequent sputum isolates compared to non-sputum isolates for the 
majority of SNVs in both patients (Patient 1: 51/54 SNVs with p<0.05 after Benjamini-Hochberg 
correction, Patient 2: 61/64 SNVs with p<0.05 after Benjamini-Hochberg correction), suggesting 
that sputum isolates tended to be more similar to the initial sputum isolate used as a reference, 
even for Patient 1 where 3/3 subsequent sputum isolates were post-transplant 
(immunosuppressed). This also suggests that non-sputum isolates harboured additional 
diversity that was not well-sampled using sputum.  
Discussion 
In this retrospective study we sought to establish the extent of within-patient variability of M. 
abscessus in two patients who developed severe complications following lung transplant as part 
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of treatment for CF. We used WGS to characterise this variability in isolates from longitudinal 
clinical samples, and were able to reveal patterns of linkage of SNVs consistent with the 
presence of multiple subpopulations within patients.  
Isolates from the same patient were similar — for example, all within-patient inter-isolate 
distances were within the threshold of 25 SNVs previously suggested for inferring potential 
transmission events25, and while mixed populations could theoretically lead to different 
transmission inferences, here between-patient variation was significantly larger — but this 
does not mean that the variation is not clinically significant. We have demonstrated that within-
patient variation can contain biologically and clinically important variation. Notably, we 
observed that variation at rrl 2058/2059, associated with macrolide resistance, developed over 
the course of treatment. We observed extensive variation in isolates from Patient 2 prior to and 
on the day of transplant (i.e. before the patient was immunosuppressed). Isolates from Patient 1 
prior to and on the day of transplant displayed no variation at these positions, so presumably 
the phenotypic macrolide resistance reported in these samples at this time was due entirely to 
inducible resistance conferred by erm(41). Nonetheless, rrl 2058/2059 variants were present in 
later isolates, suggesting that macrolide use still has a therapeutic impact even in the presence 
of a functional erm(41) gene and drives the selection of high-level macrolide resistance. We also 
observed variation in the rrs gene, another source of resistance to antibiotics targeting 
ribosomal function (e.g. amikacin), at both previously recorded and novel positions, including 
an allele that rose in dominance over the course of treatment in Patient 2 (Figure 4). 
When resistance to antibiotics is driven by point mutations at single positions, natural mutation 
rates will lead to the repeated presence of naturally occurring resistant cells. Conservatively 
taking values from the more slow-growing and non-recombining M. tuberculosis, a mutation 
rate of ~8x10-9 mutations per site per month26 and a typical extracellular population of ~109 
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cells27 clearly means that during treatment a typical within-patient population will repeatedly 
give rise to cells with the rrl 2058 mutation (for example). Typically such mutations have fitness 
costs, so remain at low frequency, but in the presence of antibiotics they rapidly achieve 
dominance. In M. tuberculosis, combination therapy is specifically designed to combat this 
selection of resistance. The strong resistance selection effect we observe for macrolides in M. 
abscessus highlights the weakness of current treatment regimens, particularly the lack of good 
companion medications. 
Based on this data we would question how useful phenotypic testing of isolates recovered from a 
limited number of sputum isolates is for guiding antimicrobial therapy, as this strategy is 
unlikely to capture the diversity present in the full sample. Similarly, even though WGS is clearly 
a valuable tool, if restricted to the analysis of sputum isolates it may also fail to capture an 
accurate AMR profile. Previous studies on M. tuberculosis have shown that mycobacterial 
culture reduces the diversity recovered from sputum samples28,29. It is therefore possible that 
the diversity found across different sample sites in this study may have been present in sputum 
samples, but lost in the culture step. For M. tuberculosis, direct sequencing from sputum samples 
using capture-based enrichment methods has been shown to recover sample diversity not 
present in liquid culture30. Extending this to this case, it is possible that WGS at high depth 
applied directly to sputum samples could identify the variants detected between sample sites.  
We observed highly variable positions in genes with direct relevance for the survival of M. 
abscessus across different physiological niches e.g. the regulation of ferric uptake (MAB_1678c) 
and the control of cell division (MAB_0347). In a chronic infection, mycobacteria must cope with 
considerable host stresses, including Fe starvation, which enables the persistence of M. 
tuberculosis in granulomas31. Phenotypic diversity due to expression can also occurs: colony 
morphotype (‘smooth’ or ‘rough’) has previously been linked to phenotype, although both 
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciz069/5301759 by guest on 05 February 2019
 M. abscessus subclones in CF patients 
14 
 
 
 
 
morphotypes appear to be capable of aggregation and intracellular survival32. Further diversity 
may come from the subpopulations harboured at different locations within the patient’s lung. 
Regional selective pressures within the lung have been shown to drive the diversification of 
Pseudomonas aeruginosa, another chronic CF pathogen, and we would expect similar dynamics 
for M. abscessus. In particular, different body regions may have different antibiotic antibiotic 
concentrations. It has been recently shown for M. tuberculosis that antibiotic concentrations 
vary across biopsy sites in cavities, and that this variation is associated with different MICs and 
resistance-associated variants7. It seems highly plausible that similar effects exist in M. 
abscessus infections, and this is an important area for further research.  
Our findings suggest that the wider diversity present within patients chronically infected with 
M. abscessus is not well-sampled with sputum, and that body site influences subpopulation 
structure. More widespread sampling of multiple body sites would provide a more accurate 
picture of the AMR profile of M. abscessus infecting a patient, and may be necessary to guide 
targeted antimicrobial therapy prior to transplant. However, in practical terms this would mean 
taking biopsies, which carries a significant clinical risk and would probably be unfeasible in 
patients awaiting transplant. An alternative solution to improve patient management before 
transplant might rely on deep-sequencing of multiple sputum samples. Such a strategy might capture a 
sufficient fraction of the total within-patient diversity to provide accurate information about the presence 
of minor variants, in particular those conferring AMR. 
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Tables 
 
 Patient 1 Patient 2 
Total bases 5,172,759 5,275,491 
Mean depth of 
coverage  
25.3X  74.1X 
Number of contigs  28 46 
 
Table 1. Summary statistics for the de novo reference genomes of the two patients in this 
study. References were assembled for the first temporal sample from each patient 
(patient_1_S1 and patient_2_S1; see Methods). 
 
 
 
 Table 2: patient clinical data. Dates are relative to the day of transplant.  
 
Patient 
M. abscessus  
sub-species 
Sex CF genotype 
Date of last 
smear-
positive 
sample 
Date of last 
M. 
abscessus 
isolate 
Patient 1 ABS Female F508del/F508del -166 days +56 days 
 Patient 2 ABS Male F508del/W1282X -81 days +59 days 
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Sample Body site 
Date 
isolate
d 
Colony 
morphotyp
e 
VNTR 
profile 
Phenotypic susceptibility 
patient_1_S1 Sputum -166 
days 
Rough I Amikacin-S; Cipro-R; 
Clarithromycin-R; Doxycycline-R; 
Augmentin-R 
patient_1_S2 Lung tissue 0 days Rough I Amikacin-PR; Cipro-R; 
Clarithromycin-R; Doxycycline-R; 
Linezolid-R; Co-trem-R; 
Cefotaxime-R 
patient_1_S3 Sputum 10 days Smooth I n/a 
patient_1_S4 Sputum 15 days Rough I n/a 
patient_1_S5 Pleural 
Fluid 
21 days Smooth I n/a 
patient_1_S6 Pleural 
Fluid 
38 days Rough I* n/a 
patient_1_S7 Pleural 
Fluid 
38 days Rough I* n/a 
patient_1_S8 Pleural 
Fluid 
40 days Smooth I* n/a 
patient_1_S9 BAL 42 days Smooth I* n/a 
patient_1_S10 Pleural 
Fluid 
49 days Smooth I* n/a 
patient_1_S11 Pleural 
Fluid 
49 days Smooth I* n/a 
patient_1_S12 Pleural 
Fluid 
49 days Smooth I* n/a 
patient_1_S13 Chest 
wound swab 
49 days Smooth I / I* n/a 
patient_1_S14 Chest 
wound swab 
49 days Smooth I n/a 
patient_1_S15 Sputum 51 days Smooth I / I * n/a 
patient_1_S16 Chest 
wound swab 
56 days Rough I n/a 
      
patient_2_S1 Sputum -121 
days 
Rough n/a Amikacin-R; Cipro-R; 
Clarithromycin-R; Doxycycline-R; 
Linezolid-R; Co-trem-R; 
Cefotaxime-R 
patient_2_S2 Sputum -81 
days 
Smooth I n/a 
patient_2_S3 Lymph node 
tissue 
0 days Rough I n/a 
patient_2_S4 Lymph node 
tissue 
0 days Smooth n/a n/a 
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Table 3: Routine microbiology data about isolates in this study. Dates are relative to the date of 
transplant for each patient. An asterisk (*) indicates that the VNTR profile differed at one locus. n/a 
indicates data not available. Phenotypic susceptibility was available for a minority of isolates 
(S=susceptible, R=resistant, PR=partially resistant).  
  
patient_2_S5 Lymph node 
tissue 
0 days Rough I n/a 
patient_2_S6 Lung tissue 0 days n/a I n/a 
patient_2_S7 Sputum 14 days Smooth n/a n/a 
patient_2_S8 BAL 27 days Smooth I n/a 
patient_2_S9 Pleural 
Fluid 
33 days Smooth I n/a 
patient_2_S10 BAL 41 days Smooth I / I* n/a 
patient_2_S11 Pleural 
Fluid 
42 days Smooth I n/a 
patient_2_S12 Pleural 
Fluid 
42 days Smooth I Amikacin-R; Ciprofloxacin-R; 
Clarithromycin-R; Doxycycline-R; 
Linezolid-R; Co-trimoxazole-R; 
Cefoxitin-R; Tobramycin-R; 
Moxyfloxacin-R 
patient_2_S13 Drain site 
swab 
49 days Smooth n/a n/a 
patient_2_S14 Pleural 
Fluid 
50 days Smooth n/a n/a 
patient_2_S15 Pleural 
Fluid 
58 days Smooth I n/a 
patient_2_S16 Pleural 
Fluid 
59 days Smooth n/a n/a 
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Figure legends 
Figure 1. Overview of the sampling scheme and antibiotic treatment. Treatment regime 
including intravenous antibiotics (boxed coloured lines) and oral antibiotics (faint coloured 
lines) for both patients during the six-month period prior to lung transplant (red vertical line). 
The sampling scheme is represented at the bottom of each panel (coloured points).  
Figure 2. Linkage patterns of SNVs across samples suggest the presence of closely-related 
subpopulations within patients. (a, b) SNVs were grouped into clusters (colours) using an 
unsupervised clustering technique, showing clear patterns of abundance across samples (see 
Methods). Genome position was inferred by ordering de novo contigs against the M. abscessus 
ATCC 19977 reference genome. (c, d) Midpoint-rooted neighbour-joining tree based on 
Euclidean distances between samples using these clustered SNVs show this variation within 
patients over time (numbers) and body site (colours). 
Figure 3. Variants in the rrl gene (23S rRNA) arise during treatment and are present in 
isolates from concurrent samples. Relative allele fractions at these positions show that 
although the initial sputum isolate was susceptible for both patients, resistance appeared to 
develop during treatment. Samples are ordered by time, with boxes indicating samples on the 
same day. Samples taken on the day of transplant are shown in bold text. N.B. Here following the 
usual convention for the rrl gene we use E. coli numbering. Positions 2058 and 2059 in E. coli 
correspond to 2269 and 2270 in M. abscessus. (S = sputum, BAL = bronchalveolar lavage, CW = 
chest wound, DSW = drain site swab, LT = lung tissue, LN = lymph node, PF = pleural fluid). 
 Figure 4. Variants in the rrs (16S rRNA) gene over the course of treatment. Patient 1: 
position 1174. Patient 2: position 1374, previously associated with amikacin resistance (see 
text). Numbering relative to ATCC 19977 reference. (S = sputum, BAL = bronchalveolar lavage, 
CW = chest wound, DSW = drain site swab, LT = lung tissue, LN = lymph node, PF = pleural 
fluid).  
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Supplementary data 
Supplementary Dataset 1. SNVs used for clustering in both patients. A list of the variant 
positions used for clustering to identify subpopulations, sorted in decreasing order of standard 
deviation across samples. In addition to the position of the variant in the de novo assembly 
reference, its position (if present) in the ATCC 19977 is given, along with the relevant UniProt 
ID. Samples are sorted in time order.  
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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